Veerhealth Care secures Rs 10.07 lakh oral care order from domestic entity

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • Veerhealth Care secured a new order worth Rs 10.07 lakh for oral care products from a domestic entity.
  • The order requires execution within 45 days and was disclosed on September 9, 2026.
  • Q2FY27 order inflows reached Rs 1133.47 crore, up from Rs 149.05 crore in Q1FY27.
  • The company reports zero consolidated revenue and net profit for the trailing twelve months.
  • Valuation metrics show a P/E of 64.9x against an ROCE of 2.55% as of September 11, 2026.
powered bylight_fuzz_icon
47475242

*this image is generated using AI for illustrative purposes only.

WHAT HAPPENED

Veerhealth Care has received a confirmed order valued at Rs 10.07 lakh from a domestic entity for the supply of oral care products. The order was disclosed to the exchange on September 9, 2026.

ORDER IN FINANCIAL CONTEXT

The Rs 10.07 lakh order value cannot be meaningfully benchmarked against average quarterly revenue, as the pre-computed average quarterly revenue is Rs 0.0 crore based on TTM data. Consequently, the book-to-bill ratio remains mathematically undefined due to zero denominator revenue. This disparity highlights that while order inflow is active, revenue recognition has not yet commenced or reported at scale.

COMPANY ORDER TRACK RECORD

Order inflow velocity has accelerated in the latest quarter. Q2FY27 saw total inflows of Rs 1133.47 crore, a sharp increase from Rs 149.05 crore in Q1FY27. The company has now received orders from multiple entity types, including domestic, international, and entities not disclosed as per confidential terms.

Quarter Total Order Inflow (Rs Cr) Key Awarding Entities
Q2FY27 (Jul-Sep 2026) 1133.47 Domestic, Not disclosed as per confidential terms, one of India's leading FMCG company
Q1FY27 (Apr-Jun 2026) 149.05 Not disclosed as per confidential terms

ORDER HISTORY

Order Date Order Value Awarding Entity Terms
09 Sep 2026 Rs 10.07 lakh Not disclosed as per confidential terms Supply of oral care products; execute within 45 days
02 Sep 2026 Rs 436.99 lakh Not disclosed as per confidential terms Supply of face care products; execute within 45 days
04 Aug 2026 Rs 526.84 lakh Domestic Supply of face care products
23 Jul 2026 Rs 76.4 lakh One of India's leading FMCG company New sample order for supply of skin care products under a new MRP structure for brand promotion and market expansion
24 Jul 2026 Rs 15.73 lakh Not disclosed as per confidential terms Supply of gripe water
22 Jul 2026 Rs 76.4 lakh Not disclosed as per confidential terms Supply of skincare products, contract manufacturing order under a new MRP structure for brand promotion and market expansion
11 Jul 2026 Rs 1.11 crore Not disclosed as per confidential terms Supply of haircare and oral care products
15 May 2026 Rs 2.45 crore Not disclosed as per confidential terms Supply of face care products; execute within 45 days
29 Apr 2026 Rs 143.0 lakh Not disclosed as per confidential terms FOB Nhava seva, supply of body care products
09 Jun 2026 Rs 3.6 crore Not disclosed as per confidential terms Supply of face care products

EXECUTION AND REVENUE QUALITY

The company reports zero consolidated revenue, net profit, and operating profit margin for the trailing twelve months. This indicates that existing backlogs are not currently converting to recognized revenue in the audited financials provided.

Period Revenue (Rs Cr) Net Profit (Rs Cr) OPM (%)
TTM 0.0 0.0 0.0%

WORKING CAPITAL AND EXECUTION CAPACITY

Balance sheet and cashflow data are not explicitly provided in the input for detailed liquidity analysis. With zero operating cashflow and zero revenue, the company's ability to fund working capital for the existing backlog depends entirely on external financing or promoter support. The absence of reported liabilities or equity figures prevents a precise current ratio assessment, but the lack of revenue generation poses a fundamental working capital constraint until orders begin converting to billings.

WHAT TO WATCH

  • Execution rate: Quarterly revenue run-rate vs total backlog is currently zero; watch for the first instance of revenue recognition to validate execution capability.
  • Margin quality: OPM trajectory on new orders vs historical average is unobservable; initial revenue filings will reveal whether these contracts carry healthy margins.
  • Client concentration: A significant portion of the order book comes from entities listed as "Not disclosed as per confidential terms," making it difficult to assess true client concentration risk beyond the named partners.
  • Revenue recognition lag: The gap between Rs 1133.47 crore in recent order inflows and Rs 0.0 crore in TTM revenue requires monitoring to ensure orders are translating into billable milestones.
  • Entity diversity: Veerhealth Care has now received orders from domestic, international, and undisclosed counterparties across the last two fiscal quarters.

KEY OBSERVATIONS

  • Valuation check (as of 11 Sep 2026): P/E of 64.9x against ROCE of 2.55%. Valuation is pricing in execution improvement not yet visible in return ratios. (P/E is price-derived and will change; ROCE is from audited financials)
  • Backlog signal: Book-to-bill is undefined due to zero TTM revenue. At this level, execution capacity becomes the binding constraint, as the entire order book must be converted to revenue to justify current market expectations.

Historical Stock Returns for Veerhealth Care

1 Day5 Days1 Month6 Months1 Year5 Years
+0.20%-0.02%+2.36%+150.03%+173.71%+412.62%

Veerhealth Care schedules 34th AGM for September 23, 2026

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Veerhealth Care schedules its 34th AGM for September 23, 2026
  • The meeting will be held via video conferencing at 4:00 pm
  • The FY26 Annual Report is available on the company website
  • Shareholders must update KYC details for electronic payments
powered bylight_fuzz_icon
49743695

*this image is generated using AI for illustrative purposes only.

Veerhealth Care has scheduled its 34th Annual General Meeting for Wednesday, September 23, 2026. The event will be conducted through video conferencing or other audio-visual means at 4:00 pm.

Meeting Details

The company notified the BSE Limited on August 31, 2026, regarding the upcoming shareholder meeting. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Notice of the 34th Annual General Meeting along with the Annual Report for FY26 will be made available on the company website at www.veerhealthcare.net .

Detail Information
Meeting Date September 23, 2026
Time 4:00 pm
Mode Video Conferencing / OAVM
Annual Report Link www.veerhealthcare.net

Regulatory Compliance

Pursuant to Regulation 36(1)(b) of the SEBI Listing Regulations, the company sent letters containing the web link to the annual report to members without registered email IDs as of August 21, 2026.

Shareholders holding physical securities are reminded to update their KYC details, including PAN, bank account information, and nomination choices, in accordance with SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37. Payments for folios lacking updated details will be made only via electronic mode.

Historical Stock Returns for Veerhealth Care

1 Day5 Days1 Month6 Months1 Year5 Years
+0.20%-0.02%+2.36%+150.03%+173.71%+412.62%

What specific strategic initiatives or financial targets will management highlight in the FY26 Annual Report during the AGM?

How might the shift to mandatory electronic payments for shareholders with outdated KYC details impact Veerhealth Care's operational efficiency and shareholder engagement metrics?

Are there any proposed changes to the board of directors or executive compensation packages that shareholders should scrutinize at the upcoming meeting?

More News on Veerhealth Care

1 Year Returns:+173.71%